Link Pharma Chem Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 9.12 | 8.02 | 8.31 |
| Operating Expense | 8.30 | 7.11 | 7.66 |
| Net Profit | 0.30 | 0.26 | 0.22 |
| Net Profit Margin | 3.29 | 3.24 | 2.65 |
| Earning Per Share | 0.67 | 0.59 | 0.50 |
| EBIDTA | 0.76 | 0.70 | 0.72 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2024 |
|---|---|
| Revenue | 9.12 |
| Operating Expense | 8.30 |
| Net Profit | 0.30 |
| Net Profit Margin | 3.29 |
| Earning Per Share | 0.67 |
| EBIDTA | 0.76 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 29.90 | 38.76 | 53.56 |
| Operating Expenses Annual | 30.55 | 36.04 | 50.02 |
| Operating Profit Annual | -0.01 | 2.57 | 4.00 |
| Interest Annual | 0.87 | 0.76 | 0.45 |
| Depreciation | 1.03 | 0.92 | 0.93 |
| Net Profit Annual | -1.36 | 0.65 | 1.88 |
| Tax Annual | -0.55 | 0.23 | 0.74 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 29.90 |
| Operating Expenses Annual | 30.55 |
| Operating Profit Annual | -0.01 |
| Interest Annual | 0.87 |
| Depreciation | 1.03 |
| Net Profit Annual | -1.36 |
| Tax Annual | -0.55 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.09 | 0.27 | 4.22 |
| Cash Flow from Operations | -0.03 | -1.71 | -1.26 |
| Cash Flow from Investing | 0.41 | -0.08 | -4.97 |
| Cash Flow from Financing | -0.41 | 1.61 | 2.27 |
| Cash Flow at the End | 0.06 | 0.09 | 0.27 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 0.09 |
| Cash Flow from Operations | -0.03 |
| Cash Flow from Investing | 0.41 |
| Cash Flow from Financing | -0.41 |
| Cash Flow at the End | 0.06 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | -0.03 | 6.63 | 6.29 |
| PBIT Margin (%) | -3.48 | 4.26 | 4.56 |
| PBT Margin (%) | 0.53 | -1.31 | -5.56 |
| Net PROFIT Margin (%) | -4.55 | 1.68 | 3.51 |
| Return On Networth / Equity (%) | -9.46 | 4.41 | 10.65 |
| Return On Networth /Employed (%) | -4.43 | 7.31 | 13.09 |
| Return On Assets (%) | -5.78 | 2.90 | 10.07 |
| Total Debt / Equity (X) | 0.63 | 0.51 | 0.37 |
| Asset Turnover Ratio (%) | 1.27 | 1.73 | 2.87 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | -0.03 |
| PBIT Margin (%) | -3.48 |
| PBT Margin (%) | 0.53 |
| Net PROFIT Margin (%) | -4.55 |
| Return On Networth / Equity (%) | -9.46 |
| Return On Networth /Employed (%) | -4.43 |
| Return On Assets (%) | -5.78 |
| Total Debt / Equity (X) | 0.63 |
| Asset Turnover Ratio (%) | 1.27 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 9.94 | 9.00 | 8.79 |
| Total Current Assets Annual | 11.53 | 17.55 | 13.57 |
| Non Current Assets Annual | 14.42 | 14.91 | 15.39 |
| Total Shareholders Funds Annual | 13.71 | 15.04 | 14.47 |
| Total Assets Annual | 25.95 | 32.46 | 28.96 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 9.94 |
| Total Current Assets Annual | 11.53 |
| Non Current Assets Annual | 14.42 |
| Total Shareholders Funds Annual | 13.71 |
| Total Assets Annual | 25.95 |
No Data Availabe
